S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
S&P 500   4,701.21 (+0.31%)
DOW   35,754.75 (+0.10%)
QQQ   399.61 (+0.45%)
AAPL   175.08 (+2.28%)
MSFT   334.97 (+0.01%)
FB   330.56 (+2.40%)
GOOGL   2,963.73 (+0.62%)
AMZN   3,523.16 (+0.00%)
TSLA   1,068.96 (+1.64%)
NVDA   318.26 (-1.85%)
BABA   125.08 (-0.37%)
NIO   35.05 (+5.83%)
CGC   10.94 (+2.82%)
AMD   145.24 (+0.27%)
GE   98.28 (+0.75%)
MU   86.02 (+0.22%)
T   23.17 (+0.39%)
F   19.81 (-0.75%)
DIS   153.34 (+1.68%)
PFE   51.40 (-0.62%)
AMC   32.35 (+4.22%)
ACB   6.57 (+2.98%)
BA   211.03 (+1.05%)
NASDAQ:QDEL

Quidel Stock Forecast, Price & News

$142.65
-0.56 (-0.39%)
(As of 12/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$140.07
$144.51
50-Day Range
$121.10
$152.50
52-Week Range
$103.31
$265.00
Volume
286,238 shs
Average Volume
756,934 shs
Market Capitalization
$5.94 billion
P/E Ratio
6.99
Dividend Yield
N/A
Beta
-0.24
30 days | 90 days | 365 days | Advanced Chart
Receive QDEL News and Ratings via Email

Sign-up to receive the latest news and ratings for Quidel and its competitors with MarketBeat's FREE daily newsletter.


Quidel logo

About Quidel

Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA.

Headlines

Quidel (NASDAQ:QDEL) Stock Price Down 4.1%
December 1, 2021 |  americanbankingnews.com
Quidel Statement on the Omicron Variant - Business Wire
December 1, 2021 |  businesswire.com
Quidel Statement on the Omicron Variant - Yahoo Finance
November 30, 2021 |  finance.yahoo.com
Quidel Statement on the Omicron Variant
November 30, 2021 |  finance.yahoo.com
Quidel (NASDAQ:QDEL) Shares Gap Up to $131.66
November 26, 2021 |  americanbankingnews.com
Quidel (NASDAQ:QDEL) Stock Price Down 8.5%
November 23, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:QDEL
CUSIP
74838J10
Employees
1,370
Year Founded
1979

Sales & Book Value

Annual Sales
$1.66 billion
Cash Flow
$21.01 per share
Book Value
$39.21 per share

Profitability

Net Income
$810.29 million
Pretax Margin
60.96%

Debt

Price-To-Earnings

Miscellaneous

Free Float
40,550,000
Market Cap
$5.94 billion
Optionable
Optionable

Company Calendar

Last Earnings
11/04/2021
Today
12/08/2021
Fiscal Year End
12/31/2021
Next Earnings (Estimated)
2/17/2022

Social Links


MarketRank

Overall MarketRank

1.79 out of 5 stars

Medical Sector

851st out of 1,394 stocks

Diagnostic Substances Industry

10th out of 25 stocks

Analyst Opinion: 1.5Community Rank: 4.5Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -












Quidel (NASDAQ:QDEL) Frequently Asked Questions

Is Quidel a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quidel in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Quidel stock.
View analyst ratings for Quidel
or view top-rated stocks.

How has Quidel's stock been impacted by COVID-19 (Coronavirus)?

Quidel's stock was trading at $89.68 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, QDEL stock has increased by 59.1% and is now trading at $142.65.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Quidel?

Quidel saw a increase in short interest in October. As of October 29th, there was short interest totaling 3,580,000 shares, an increase of 17.8% from the October 14th total of 3,040,000 shares. Based on an average daily volume of 494,600 shares, the short-interest ratio is presently 7.2 days. Currently, 9.8% of the company's stock are sold short.
View Quidel's Short Interest
.

When is Quidel's next earnings date?

Quidel is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for Quidel
.

How were Quidel's earnings last quarter?

Quidel Co. (NASDAQ:QDEL) issued its earnings results on Thursday, November, 4th. The company reported $5.36 earnings per share for the quarter, topping the Zacks' consensus estimate of $3.52 by $1.84. The firm had revenue of $509.70 million for the quarter, compared to analyst estimates of $344.25 million. Quidel had a trailing twelve-month return on equity of 62.24% and a net margin of 47.20%. Quidel's revenue for the quarter was up 7.1% compared to the same quarter last year. During the same period in the prior year, the business posted $5.68 earnings per share.
View Quidel's earnings history
.

What guidance has Quidel issued on next quarter's earnings?

Quidel issued an update on its third quarter 2021 earnings guidance on Thursday, October, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $505 million-$510 million.

What price target have analysts set for QDEL?

3 Wall Street analysts have issued twelve-month target prices for Quidel's stock. Their forecasts range from $80.00 to $219.00. On average, they anticipate Quidel's share price to reach $148.50 in the next twelve months. This suggests a possible upside of 4.1% from the stock's current price.
View analysts' price targets for Quidel
or view top-rated stocks among Wall Street analysts.

Who are Quidel's key executives?

Quidel's management team includes the following people:
  • Douglas C. Bryant, President, Chief Executive Officer & Director
  • Robert Joseph Bujarski, Chief Operating Officer
  • Randall J. Steward, Chief Financial & Accounting Officer
  • Werner Kroll, Senior Vice President-Research & Development
  • Karen C. Gibson, SVP-Information Systems & Business Transformation

What is Doug Bryant's approval rating as Quidel's CEO?

47 employees have rated Quidel CEO Doug Bryant on Glassdoor.com. Doug Bryant has an approval rating of 76% among Quidel's employees.

What other stocks do shareholders of Quidel own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Quidel investors own include NVIDIA (NVDA), DocuSign (DOCU), Tesla (TSLA), PayPal (PYPL), Shopify (SHOP), Square (SQ), Teladoc Health (TDOC), Netflix (NFLX), Advanced Micro Devices (AMD) and Zoom Video Communications (ZM).

What is Quidel's stock symbol?

Quidel trades on the NASDAQ under the ticker symbol "QDEL."

Who are Quidel's major shareholders?

Quidel's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (7.84%), Wellington Management Group LLP (4.16%), ArrowMark Colorado Holdings LLC (2.39%), Oracle Investment Management Inc. (2.18%), Senvest Management LLC (2.08%) and LGT Capital Partners LTD. (1.86%). Company insiders that own Quidel stock include Charles P Slacik, Douglas C Bryant, Edward Keith Russell, Edward L Michael, Mary Lake Ph D Polan, Matthew Strobeck, Michael Donald Jr Abney, Randall J Steward, Ratan S Borkar, Robert Joseph Bujarski, Werner Kroll, William J Ferenczy and William J Ferenczy.
View institutional ownership trends for Quidel
.

Which major investors are selling Quidel stock?

QDEL stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, AXA S.A., Voloridge Investment Management LLC, Invesco Ltd., LGT Capital Partners LTD., BlackRock Inc., Goldman Sachs Group Inc., and Gotham Asset Management LLC. Company insiders that have sold Quidel company stock in the last year include Charles P Slacik, Mary Lake Ph D Polan, Werner Kroll, and William J Ferenczy.
View insider buying and selling activity for Quidel
or view top insider-selling stocks.

Which major investors are buying Quidel stock?

QDEL stock was acquired by a variety of institutional investors in the last quarter, including Barrow Hanley Mewhinney & Strauss LLC, Senvest Management LLC, Wellington Management Group LLP, ArrowMark Colorado Holdings LLC, Russell Investments Group Ltd., Dimensional Fund Advisors LP, Man Group plc, and Oracle Investment Management Inc.. Company insiders that have bought Quidel stock in the last two years include Douglas C Bryant, Edward L Michael, and Matthew Strobeck.
View insider buying and selling activity for Quidel
or or view top insider-buying stocks.

How do I buy shares of Quidel?

Shares of QDEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Quidel's stock price today?

One share of QDEL stock can currently be purchased for approximately $142.65.

How much money does Quidel make?

Quidel has a market capitalization of $5.94 billion and generates $1.66 billion in revenue each year. The company earns $810.29 million in net income (profit) each year or $20.40 on an earnings per share basis.

How many employees does Quidel have?

Quidel employs 1,370 workers across the globe.

When was Quidel founded?

Quidel was founded in 1979.

What is Quidel's official website?

The official website for Quidel is www.quidel.com.

Where are Quidel's headquarters?

Quidel is headquartered at 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121.

How can I contact Quidel?

Quidel's mailing address is 9975 SUMMERS RIDGE ROAD, SAN DIEGO CA, 92121. The company can be reached via phone at (858) 552-1100, via email at [email protected], or via fax at 858-453-4338.


This page was last updated on 12/8/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.